Literature DB >> 22911378

The distribution of FRAX(®)-based probabilities in women from Japan.

John A Kanis1, Helena Johansson, Anders Odén, Eugene V McCloskey.   

Abstract

New assessment guidelines for osteoporosis in Japan include the use of the WHO risk assessment tool (FRAX) that computes the 10-year probability of fracture. The aim of this study was to determine the distribution of fracture probabilities and to assess the impact of probability-based intervention thresholds in women from Japan aged 50 years and older. Age-specific simulation cohorts were constructed from the prevalences of clinical risk factors and femoral neck bone mineral density to determine the distribution of fracture probabilities as assessed by FRAX. These data were used to estimate the number and proportion of women at or above a 10-year fracture probability of 5, 10, 15, 20, 25, and 30 %. In addition, case scenarios that applied a FRAX probability threshold of 15 % were compared with current guidance. In the absence of additional criteria for treatment, a 15 % fracture probability threshold would identify approximately 32 % of women over the age of 50 years (9.3 million women) as eligible for treatment. Because of expected changes in population demography, the 15 % fracture probability threshold would capture approximately 38 % of women over the age of 50 years (12.7 million women), mainly those aged 80 years or older. The introduction of a FRAX threshold of 15 % would permit treatment in women with clinical risk factors that would otherwise fall below previously established intervention thresholds. The incorporation of FRAX into assessment guidelines is likely to redirect treatments for osteoporosis from younger women at low risk to elderly women at high fracture risk.

Entities:  

Mesh:

Year:  2012        PMID: 22911378     DOI: 10.1007/s00774-012-0371-3

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  25 in total

1.  Diagnostic criteria for primary osteoporosis: year 2000 revision.

Authors:  H Orimo; Y Hayashi; M Fukunaga; T Sone; S Fujiwara; M Shiraki; K Kushida; S Miyamoto; S Soen; J Nishimura; Y Oh-Hashi; T Hosoi; I Gorai; H Tanaka; T Igai; H Kishimoto
Journal:  J Bone Miner Metab       Date:  2001       Impact factor: 2.626

2.  2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

Authors:  Alexandra Papaioannou; Suzanne Morin; Angela M Cheung; Stephanie Atkinson; Jacques P Brown; Sidney Feldman; David A Hanley; Anthony Hodsman; Sophie A Jamal; Stephanie M Kaiser; Brent Kvern; Kerry Siminoski; William D Leslie
Journal:  CMAJ       Date:  2010-10-12       Impact factor: 8.262

Review 3.  FRAX and its applications to clinical practice.

Authors:  John A Kanis; Anders Oden; Helena Johansson; Fredrik Borgström; Oskar Ström; Eugene McCloskey
Journal:  Bone       Date:  2009-02-03       Impact factor: 4.398

4.  A revised clinician's guide to the prevention and treatment of osteoporosis.

Authors:  Bess Dawson-Hughes
Journal:  J Clin Endocrinol Metab       Date:  2008-06-10       Impact factor: 5.958

Review 5.  FRAX(®) with and without bone mineral density.

Authors:  John A Kanis; Eugene McCloskey; Helena Johansson; Anders Oden; William D Leslie
Journal:  Calcif Tissue Int       Date:  2011-11-06       Impact factor: 4.333

6.  [A FRAX model for the assessment of fracture probability in Belgium].

Authors:  A Neuprez; H Johansson; J A Kanis; E V McCloskey; A Odén; O Bruyère; M Hiligsmann; J P Devogelaer; J M Kaufman; J Y Reginster
Journal:  Rev Med Liege       Date:  2009-12

7.  FRAX assessment of osteoporotic fracture probability in Switzerland.

Authors:  K Lippuner; H Johansson; J A Kanis; R Rizzoli
Journal:  Osteoporos Int       Date:  2009-06-11       Impact factor: 4.507

8.  Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK.

Authors:  J Compston; A Cooper; C Cooper; R Francis; J A Kanis; D Marsh; E V McCloskey; D M Reid; P Selby; M Wilkins
Journal:  Maturitas       Date:  2009-01-08       Impact factor: 4.342

9.  Recent trends in the incidence and lifetime risk of hip fracture in Tottori, Japan.

Authors:  H Hagino; K Furukawa; S Fujiwara; T Okano; H Katagiri; K Yamamoto; R Teshima
Journal:  Osteoporos Int       Date:  2008-07-17       Impact factor: 4.507

10.  Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX).

Authors:  S Fujiwara; T Nakamura; H Orimo; T Hosoi; I Gorai; A Oden; H Johansson; J A Kanis
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

View more
  14 in total

1.  Underestimated fracture risk in postmenopausal women-application of the hybrid intervention threshold.

Authors:  Y Wang; S Yu; C Hsu; C Tsai; T Cheng
Journal:  Osteoporos Int       Date:  2019-11-06       Impact factor: 4.507

2.  Burden of high fracture probability worldwide: secular increases 2010-2040.

Authors:  A Odén; E V McCloskey; J A Kanis; N C Harvey; H Johansson
Journal:  Osteoporos Int       Date:  2015-05-28       Impact factor: 4.507

3.  The added value of trabecular bone score to FRAX® to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.

Authors:  Y Su; J Leung; D Hans; O Lamy; T Kwok
Journal:  Osteoporos Int       Date:  2016-08-26       Impact factor: 4.507

Review 4.  A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Authors:  John A Kanis; Nicholas C Harvey; Cyrus Cooper; Helena Johansson; Anders Odén; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2016-07-27       Impact factor: 2.617

5.  Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal women.

Authors:  E Cheung; C-L Cheung; A W C Kung; K C B Tan
Journal:  Osteoporos Int       Date:  2013-11-06       Impact factor: 4.507

6.  The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.

Authors:  M Chakhtoura; W D Leslie; M McClung; A M Cheung; G El-Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2016-09-20       Impact factor: 4.507

Review 7.  Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: summary.

Authors:  Jawl-Shan Hwang; Ding-Cheng Chan; Jung-Fu Chen; Tien-Tsai Cheng; Chih-Hsing Wu; Yung-Kuei Soong; Keh-Sung Tsai; Rong-Sen Yang
Journal:  J Bone Miner Metab       Date:  2013-09-26       Impact factor: 2.626

8.  Percentage of the population at high risk of osteoporotic fracture in South Korea: analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data.

Authors:  J W Kim; Y-J Jeon; D-H Baek; T N Kim; J S Chang
Journal:  Osteoporos Int       Date:  2013-12-18       Impact factor: 4.507

9.  Adjusting conventional FRAX estimates of fracture probability according to the recency of sentinel fractures.

Authors:  J A Kanis; H Johansson; N C Harvey; V Gudnason; G Sigurdsson; K Siggeirsdottir; M Lorentzon; E Liu; L Vandenput; E V McCloskey
Journal:  Osteoporos Int       Date:  2020-07-01       Impact factor: 4.507

Review 10.  Management of osteoporosis of the oldest old.

Authors:  R Rizzoli; J Branco; M-L Brandi; S Boonen; O Bruyère; P Cacoub; C Cooper; A Diez-Perez; J Duder; R A Fielding; N C Harvey; M Hiligsmann; J A Kanis; J Petermans; J D Ringe; Y Tsouderos; J Weinman; J-Y Reginster
Journal:  Osteoporos Int       Date:  2014-07-15       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.